Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validating Reward-related Biomarkers to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder

NCT04024371 is registered in ClinicalTrials.gov with Maastricht University as lead sponsor.

NCT NCT04024371
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04024371 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validating Reward-related Biomarkers to Facilitate Development of New Treatments for Anhedonia and Reward Processing Deficits in Schizophrenia and Major Depressive Disorder
Lead sponsor
Maastricht University
Phase
Observational
Overall status
Completed
Start date
September 16, 2019
Completion date
February 1, 2021
Enrollment
160 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

anhedonia, physical, anhedonia, social, depression, motivation, negative symptoms with primary psychotic disorder, schizophrenia